Longitudinal change in working memory as a function of APOE genotype in midlife and old age

Scandinavian Journal of Psychology

Volumn 55, Issue 3, 2014, Pages 268-277

  Greenwood, Pamela M ^a   Espeseth, Thomas ^b   Lin, Ming Kuan ^a   Reinvang, Ivar ^b   Parasuraman, Raja ^a  

^a GEORGE MASON UNIVERSITY   (United States)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

APOE; Cognitive phenotype; Cross sectional; Longitudinal; Middle age; Old age; Working memory

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; AGING; ALZHEIMER DISEASE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; FEMALE; GENETICS; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRODROMAL SYMPTOM; SHORT TERM MEMORY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; PRODROMAL SYMPTOMS;

EID: 84901196457     PISSN: 00365564     EISSN: 14679450     Source Type: Journal    
DOI: 10.1111/sjop.12123     Document Type: Article

References (77)

1. Alexander, D. M., Williams, L. M., Gatt, J. M., Dobson-Stone, C., Kuan, S. A., Todd, E. G., et al. (2007). The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades. Biological Psychology, 75, 229-238.
2. Amieva, H., Le Goff, M., Millet, X., Orgogozo, J. M., Peres, K., Barberger-Gateau, P., et al. (2008). Prodromal Alzheimer's disease: Successive emergence of the clinical symptoms. Annals of Neurology, 64, 492-498.
3. Andrews-Hanna, J. R., Snyder, A. Z., Vincent, J. L., Lustig, C., Head, D., Raichle, M. E. & Buckner, R. L. (2007). Disruption of large-scale brain systems in advanced aging. Neuron, 56, 924-935.
4. Aslanidis, C. & Schmitz, G. (1999). High-speed apolipoprotein E genotyping and apolipoprotein B3500 mutation detection using real-time fluorescence PCR and melting curves. Clinical Chemistry, 45, 1094-1097.
5. Aulchenko, Y. S., Ripke, S., Isaacs, A. & van Duijn, C. M. (2007). GenABEL: an R library for genome-wide association analysis. Bioinformatics, 23, 1294-1296.
6. Bartzokis, G., Lu, P. H., Geschwind, D. H., Tingus, K., Huang, D., Mendez, M. F., et al. (2007). Apolipoprotein E affects both myelin breakdown and cognition: implications for age-related trajectories of decline into dementia. Biologocal Psychiatry, 62, 1380-1387.
7. Blair, C. K., Folsom, A. R., Knopman, D. S., Bray, M. S., Mosley, T. H. & Boerwinkle, E. & Atherosclerosis Risk in Communities Study, Investigators. (2005). APOE genotype and cognitive decline in a middle-aged cohort. Neurology, 64, 268-276.
8. Buckner, R. L., Andrews-Hanna, J. R. & Schacter, D. L. (2008). The brain's default network: anatomy, function, and relevance to disease. Annals of the New York Academy of Sciences, 1124, 1-38.
9. Bunce, D., Bielak, A. A., Anstey, K. J., Cherbuin, N., Batterham, P. J. & Easteal, S. (2014). APOE genotype and cognitive change in young, middle-aged, and older adults living in the community. Journal of Gerontology Series A: Biological Sciences and Medical Sciences, 69, 379-386.
10. Caselli, R. J., Dueck, A. C., Osborne, D., Sabbagh, M. N., Connor, D. J., Ahern, G. L., et al. (2009). Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. New England Journal of Medicine, 361, 255-263.
11. Chen, K., Reiman, E. M., Alexander, G. E., Caselli, R. J., Gerkin, R., Bandy, D., et al. (2007). Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. American Journal of Psychiatry, 164, 916-921.
12. Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C. Jr & Pericak-Vance, M. A. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics, 7, 180-184.
13. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., et al. (1993). Gene dose of Apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921-923.
14. Dean, D. C. III, Jerskey, B. A., Chen, K., Protas, H., Thiyyagura, P., Roontiva, A. E. M., et al. (2014). Brain Differences in infants at differential genetic risk for late-onset Alzheimer sisease: A cross-sectional imaging study. JAMA Neurology, 71, 11-22.
15. Dennis, N. A., Browndyke, J. N., Stokes, J., Need, A., Burke, J. R., Welsh-Bohmer, K. A. & Cabeza, R. (2010). Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers. Alzheimers & Dementia, 6, 303-311.
16. Donix, M., Burggren, A. C., Suthana, N. A., Siddarth, P., Ekstrom, A. D., Krupa, A. K., et al. (2010). Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism. Neuroimage, 53, 37-43.
17. Espeseth, T., Christoforou, A., Lundervold, A. J., Steen, V. M., Le Hellard, S. & Reinvang, I. (2012). Imaging and cognitive genetics: The Norwegian cognitive neurogenetics sample. Twin Research and Human Genetics, 15, 442-452.
18. Espeseth, T., Greenwood, P. M., Reinvang, I., Fjell, A. M., Walhovd, K. B., Westlye, L. T., et al. (2006). Interactive effects of APOE and CHRNA4 on attention and white matter volume in healthy middle-aged and older adults. Cognitive, Affective & Behavioral Neuroscience, 6, 31-43.
19. Espeseth, T., Westlye, L. T., Walhovd, K. B., Fjell, A. M., Endestad, T., Rootwelt, H. & Reinvang, I. (2012). Apolipoprotein E epsilon4-related thickening of the cerebral cortex modulates selective attention. Neurobiological Aging, 33, 304-322.
20. Filippini, N., MacIntosh, B. J., Hough, M. G., Goodwin, G. M., Frisoni, G. B., Smith, S. M., et al. (2009). Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proceedings of the National Academy of Sciences of the USA, 106, 7209-7214.
21. Fjell, A. M., McEvoy, L., Holland, D., Dale, A. M., Walhovd, K. B., Neuroimaging, Alzheimer's Disease & Initiative (2013). Brain changes in older adults at very low risk for Alzheimer's disease. Journal of Neuroscience, 33, 8237-8242.
22. Flory, J. D., Manuck, S. B., Ferrell, R. E., Ryan, C. M. & Muldoon, M. F. (2000). Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. American Journal of Medical Genetics, 96, 707-711.
23. Folstein, M. F., Folstein, S. E. & McHugh, P. R. (1975). "Mini-mental state" - a practical method for grading the cognitive state of patients for the clinician. Journal of Current Psychiatric Research, 12, 189-198.
24. Goveas, J. S., Xie, C., Chen, G., Li, W., Ward, B. D., Franczak, M. B., et al. (2013). Functional network endophenotypes unravel the effects of apolipoprotein E epsilon 4 in middle-aged adults. PLoS One, 8(2), e55902. doi:10.1371/journal.pone.0055902.
25. Gray, J. R., Chabris, C. F. & Braver, T. S. (2003). Neural mechanisms of general fluid intelligence. Nature Neuroscience, 6, 316-322.
26. Greenwood, P. M., Lambert, C., Sunderland, T. & Parasuraman, R. (2005). Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: Results from the National Institute of Mental Health' s BIOCARD study. Neuropsychology, 19(2), 199-211.
27. Greenwood, P. M., Lin, M. K., Sundararajan, R., Fryxell, K. J. & Parasuraman, R. (in press). Healthy aging increases the cognitive effects of two genes that influence extracellular dopamine. Psychological Aging.
28. Greenwood, P. M. & Parasuraman, R. (2003). Normal genetic variation, cognition, and aging. Behavioral and Cognitive Neuroscience Reviews, 2, 278-306.
29. Greenwood, P. M., Sundararajan, R., Lin, M. K., Kumar, R., Fryxell, K. J. & Parasuraman, R. (2009). Both a nicotinic single nucleotide polymorphism (SNP) and a noradrenergic SNP modulate working memory performance when attention is manipulated. Journal of Cognitive Neuroscience, 21, 2139-2153.
30. Greenwood, P. M., Sunderland, T., Friz, J. L. & Parasuraman, R. (2000). Genetics and visual attention: Selective deficits in healthy adult carriers of the varepsilon 4 allele of the apolipoprotein E gene. Proceedings of the National Academy of Sciences of the USA, 97, 11661-11666.
31. Han, S. D. & Bondi, M. W. (2008). Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Alzheimers & Dementia, 4, 251-254.
32. Hardy, J. (2006). Has the amyloid cascade hypothesis for Alzheimer's disease been proved? Current Alzheimer Research, 3, 71-73.
33. Ihle, A., Bunce, D. & Kliegel, M. (2012). APOE epsilon4 and cognitive function in early life: A meta-analysis. Neuropsychology, 26(3), 267-277.
34. Jochemsen, H. M., Muller, M., van der Graaf, Y. & Geerlings, M. I. (2012). APOE epsilon4 differentially influences change in memory performance depending on age. The SMART-MR study. Neurobiological Aging, 33, 815-822.
35. Kantarci, K., Lowe, V., Przybelski, S. A., Weigand, S. D., Senjem, M. L., Ivnik, R. J., et al. (2012). APOE modifies the association between Abeta load and cognition in cognitively normal older adults. Neurology, 78, 232-240.
36. Knickmeyer, R. C., Wang, J., Zhu, H., Geng, X., Woolson, S., Hamer, R. M., et al. (2013). Common variants in psychiatric risk genes predict brain structure at birth. Cerebral Cortex, doi:10.1093/cercor/bhs401.
37. Kok, E., Haikonen, S., Luoto, T., Huhtala, H., Goebeler, S., Haapasalo, H. & Karhunen, P. J. (2009). Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. Annals of Neurology, 65, 650-657.
38. Kozauer, N. A., Mielke, M. M., Chan, G. K., Rebok, G. W. & Lyketsos, C. G. (2008). Apolipoprotein E genotype and lifetime cognitive decline. International Psychogeriatrics, 20, 109-123.
39. Kukolja, J., Thiel, C. M., Eggermann, T., Zerres, K. & Fink, G. R. (2010). Medial temporal lobe dysfunction during encoding and retrieval of episodic memory in non-demented APOE epsilon4 carriers. Neuroscience, 168, 487-497.
40. Lippa, C. F., Smith, T. W., Saunders, A. M., Hulette, C., Pulaski-Salo, D. & Roses, A. D. (1997). Apolipoprotein E-epsilon 2 and Alzheimer's disease: Genotype influences pathologic phenotype. Neurology, 48, 515-519.
41. Mahley, R. W. & Huang, Y. (2009). Alzheimer disease: Multiple causes, multiple effects of apolipoprotein E4, and multiple therapeutic approaches. Annals of Neurology, 65, 623-625.
42. Mauch, D. H., Nagler, K., Schumacher, S., Goritz, C., Muller, E. C., Otto, A. & Pfrieger, F. W. (2001). CNS synaptogenesis promoted by glia-derived cholesterol. Science, 294, 1354-1357.
43. McClearn, G. E., Johansson, B., Berg, S., Pedersen, N. L., Ahern, F., Petrill, S. A. & Plomin, R. (1997). Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science, 276, 1560-1563.
44. McGue, M. & Christensen, K. (2002). The heritability of level and rate-of-change in cognitive functioning in Danish twins aged 70 years and older. Experimental Aging Research, 28, 435-451.
45. Mondadori, C. R., de Quervain, D. J., Buchmann, A., Mustovic, H., Wollmer, M. A., Schmidt, C. F., et al. (2007). Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cerebral Cortex, 17, 1934-1947.
46. Morris, J. C., Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M. & Mintun, M. A. (2010). APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Annals of Neurology, 67, 122-131.
47. Negash, S., Greenwood, P. M., Sunderland, T., Parasuraman, R., Geda, Y. E., Knopman, D. S., et al. (2009). The influence of apolipoprotein E genotype on visuospatial attention dissipates after age 80. Neuropsychology, 23, 81-89.
48. Nygard, M., Eichele, T., Loberg, E. M., Jorgensen, H. A., Johnsen, E., Kroken, R. A., et al. (2012). Patients with schizophrenia fail to up-regulate task-positive and down-regulate task-negative brain networks: An fMRI study using an ICA analysis approach. Frontiers in Human Neuroscience, 6, 149-153.
49. O'Bryant, S. E., Humphreys, J. D., Smith, G. E., Ivnik, R. J., Graff-Radford, N. R., Petersen, R. C. & Lucas, J. A. (2008). Detecting dementia with the mini-mental state examination in highly educated individuals. Archives of Neurology, 65, 963-967.
50. Oria, R. B., Patrick, P. D., Zhang, H., Lorntz, B., de Castro Costa, C. M., Brito, G. A., et al. (2005). APOE4 protects the cognitive development in children with heavy diarrhea burdens in Northeast Brazil. Pediatric Research, 57, 310-316.
51. Parasuraman, R., Greenwood, P. M. & Sunderland, T. (2002). The apolipoprotein E gene, attention, and brain function. Neuropsychology, 16, 254-274.
52. Peters, A. (2002). The effects of normal aging on myelin and nerve fibers: A review. Journal of Neurocytology, 31, 581-593.
53. Poirier, J. (2005). Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease. Neurobiological Aging, 26, 355-361.
54. Rebeck, G. W., Alonzo, N. C., Berezovska, O., Harr, S. D., Knowles, R. B., Growdon, J. H., et al. (1998). Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes. Experimental Neurology, 149, 175-182.
55. Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., et al. (2009). Fibrillar amyloid-{beta} burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proceedings of the National Academy of Sciences of the USA, 106, 6820-6825.
56. Reinvang, I., Espeseth, T. & Westlye, L. T. (2013). APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease. Neuroscience & Biobehavioral Reviews, 37, 1322-1335.
57. Rusted, J. M., Evans, S. L., King, S. L., Dowell, N., Tabet, N. & Tofts, P. S. (2013). APOE e4 polymorphism in young adults is associated with improved attention and indexed by distinct neural signatures. Neuroimage, 65, 364-373.
58. Rypma, B., Berger, J. S., Prabhakaran, V., Bly, B. M., Kimberg, D. Y., Biswal, B. B. & D'Esposito, M. (2006). Neural correlates of cognitive efficiency. Neuroimage, 33, 969-979.
59. Shaw, P., Kabani, N. J., Lerch, J. P., Eckstrand, K., Lenroot, R., Gogtay, N., et al. (2008). Neurodevelopmental trajectories of the human cerebral cortex. Journal of Neuroscience, 28, 3586-3594.
60. Shaw, P., Lerch, J. P., Pruessner, J. C., Taylor, K. N., Rose, A. B., Greenstein, D., et al. (2010). APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Abeta42. Journal of Neuroscience, 30, 17035-17040.
61. Small, B. J., Rosnick, C. B., Fratiglioni, L. & Backman, L. (2004). Apolipoprotein E and cognitive performance: A meta-analysis. Psychological Aging, 19, 592-600.
62. Smith, G. E., Bohac, D. L., Waring, S. C., Kokmen, E., Tangalos, E. G., Ivnik, R. J. & Petersen, R. C. (1998). Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects. Neurology, 50, 355-362.
63. Sridharan, D., Levitin, D. J. & Menon, V. (2008). A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks. Proceedings of the National Academy of Sciences of the USA, 105, 12569-12574.
64. Teter, B., Xu, P. T., Gilbert, J. R., Roses, A. D., Galasko, D. & Cole, G. M. (2002). Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. Journal of Neuroscience Research, 68, 331-336.
65. Trachtenberg, A. J., Filippini, N., Cheeseman, J., Duff, E. P., Neville, M. J., Ebmeier, K. P., et al. (2012). The effects of APOE on brain activity do not simply reflect the risk of Alzheimer's disease. Neurobiological Aging, 33, 611-618.
66. Trachtenberg, A. J., Filippini, N., Ebmeier, K. P., Smith, S. M., Karpe, F. & Mackay, C. E. (2012). The effects of APOE on the functional architecture of the resting brain. Neuroimage, 59, 565-572.
67. Trachtenberg, A. J., Filippini, N. & Mackay, C. E. (2012). The effects of APOE-epsilon4 on the BOLD response. Neurobiological Aging, 33, 323-334.
68. Utermann, G., Langenbeck, U., Beisiegel, U. & Weber, W. (1980). Genetics of the apolipoprotein E system in man. American Journal of Human Genetics, 32, 339-347.
69. Wake, H., Lee, P. R. & Fields, R. D. (2011). Control of local protein synthesis and initial events in myelination by action potentials. Science, 333, 1647-1651.
70. Wechsler, D. (1981). Wechsler adult intelligence scale-revised: Manual. New York: Psychological Corporation.
71. West, M. J., Kawas, C. H., Stewart, W. F., Rudow, G. L. & Troncoso, J. C. (2004). Hippocampal neurons in pre-clinical Alzheimer's disease. Neurobiological Aging, 25, 1205-1212.
72. Westlye, L. T., Reinvang, I., Rootwelt, H. & Espeseth, T. (2012). Effects of APOE on brain white matter microstructure in healthy adults. Neurology, 79, 1961-1969.
73. White, F., Nicoll, J. A. & Horsburgh, K. (2001). Alterations in ApoE and ApoJ in relation to degeneration and regeneration in a mouse model of entorhinal cortex lesion. Experimental Neurology, 169, 307-318.
74. Wilson, R. S., Leurgans, S. E., Boyle, P. A. & Bennett, D. A. (2011). Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Archives of Neurology, 68, 351-356.
75. Wisdom, N. M., Callahan, J. L. & Hawkins, K. A. (2011). The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis. Neurobiological Aging, 32, 63-74.
76. Yu, Y. W., Lin, C. H., Chen, S. P., Hong, C. J. & Tsai, S. J. (2000). Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers. Neuroscience Letters, 294, 179-181.
77. Zivelin, A., Rosenberg, N., Peretz, H., Amit, Y., Kornbrot, N. & Seligsohn, U. (1997). Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clinical Chemistry, 43, 1657-1659.